Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Metastasis of Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT05588297
What this trial is testing

Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Liver Metastases
Shanghai Changzheng Hospital 12
Testing effectiveness (Phase 2)UnknownNCT00172159
What this trial is testing

Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)UnknownNCT00356161
What this trial is testing

HAI Via Interventionally Implanted Port Catheter Systems

Who this might be right for
Colorectal CancerLiver NeoplasmsHepatocellular Carcinoma+2 more
Charite University, Berlin, Germany 100
Testing effectiveness (Phase 2)UnknownNCT00553683
What this trial is testing

Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer

Who this might be right for
Breast CancerColorectal CancerGastric Cancer+5 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00149396
What this trial is testing

Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerLiver Neoplasms
MediGene 32
Not applicableNot Yet RecruitingNCT07031570
What this trial is testing

Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLM

Who this might be right for
Colorectal Cancer Metastatic
Peking University Cancer Hospital & Institute 500
Not applicableUnknownNCT04686942
What this trial is testing

Sonazoid-enhanced Ultrasound for the Detection of Colorectal Liver Metastases Less Than 2 cm

Who this might be right for
Liver Metastasis Colon Cancer
Sun Yat-sen University 550
Early research (Phase 1)Ended earlyNCT03029988
What this trial is testing

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

Who this might be right for
Liver MetastasesColorectal Carcinoma
Navidea Biopharmaceuticals 3
Large-scale testing (Phase 3)WithdrawnNCT00735241
What this trial is testing

FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaLiver Metastases
Sirtex Medical
Testing effectiveness (Phase 2)Study completedNCT00778102
What this trial is testing

Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 80
Testing effectiveness (Phase 2)UnknownNCT03487939
What this trial is testing

Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDrug Therapy
China Medical University, China 30
Not applicableLooking for participantsNCT05314400
What this trial is testing

Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer

Who this might be right for
Liver Metastasis Colon Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 200
Testing effectiveness (Phase 2)Study completedNCT01383707
What this trial is testing

Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 77
Not applicableStudy completedNCT06936098
What this trial is testing

Deep Learning-Based Analysis of Colorectal Cancer Pathology Images: An Innovative Approach for Predicting Colorectal Cancer Subtypes

Who this might be right for
Colorectal Liver Metastasis (CRLM)Histopathological Growth Patterns (HGPs)Artificial Intelligence (AI) in Diagnosis+2 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 431
Testing effectiveness (Phase 2)Study completedNCT00844233
What this trial is testing

Study of Chemoembolisation Using Irinotecan Bead Prior to Surgery in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Boston Scientific Corporation 40
Testing effectiveness (Phase 2)Study completedNCT00200200
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer

Who this might be right for
Hepatic MetastasesColon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 73
Early research (Phase 1)Study completedNCT00695201
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Intravenous Oxaliplatin Plus Irinotecan in Patients With Unresectable Hepatic Metastases From Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 52
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612007
What this trial is testing

HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+1 more
Mayo Clinic 80
Not applicableNot Yet RecruitingNCT07744139
What this trial is testing

Radiogenomic Profiling of Dendritic Cells and Macrophages to Predict Recurrence in Colorectal Liver Metastasis

Who this might be right for
Colo-rectal CancerLiver MetastasesColon Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 210
Next Page